Microbial/enzymatic synthesis of chiral intermediates for pharmaceuticals
- 1 November 2002
- journal article
- Published by Elsevier in Enzyme and Microbial Technology
- Vol. 31 (6) , 804-826
- https://doi.org/10.1016/s0141-0229(02)00186-2
Abstract
No abstract availableKeywords
This publication has 82 references indexed in Scilit:
- Directed Evolution of Toluene Dioxygenase from Pseudomonas putida for Improved Selectivity Toward cis-Indandiol during Indene BioconversionMetabolic Engineering, 2000
- Biocatalysis for Pharmaceuticals—Status and Prospects for a Key TechnologyMetabolic Engineering, 2000
- Application of α-keto acid decarboxylases in biotransformationsBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1998
- BMS-187257, a potent, selective, and novel heterocyclic β3 adrenergic receptor agonistBioorganic & Medicinal Chemistry Letters, 1996
- Innovations in drug research: inhibitors of thromboxane and leukotrienesClinical and Experimental Allergy, 1991
- Synthesis of Optically Active 7-Oxabicyclo[2.2.1]heptanes and Assignment of Absolute ConfigurationSynthesis, 1987
- DiltiazemDrugs, 1985
- Enantioselective Reductions of β-keto-Esters by Bakers' YeastAnnals of the New York Academy of Sciences, 1984
- Comparative effects of three calcium antagonists, diltiazem, verapamil and nifedipine, on the sinoatrial and atrioventricular nodes. Experimental and clinical studies.Circulation, 1981
- Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive AgentsScience, 1977